Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Lumira Ventures

Lumira Ventures
VC INVESTOR TYPE
Active STATUS
8 PROFESSIONALS
123 INVESTMENTS
28 PORTFOLIO
58 EXITS
Description

Lumira Ventures is a leading health and life sciences venture capital firm that invests in and helps build transformative bio-pharmaceutical and medical device companies located in North America. The firm is a North American healthcare and life sciences venture capital firm, with offices in Toronto, Montreal, Vancouver and Boston, it collaborates with and invests in entrepreneurial management teams to build best-in-class, innovation-centric biotherapeutic and medical device companies.

Formerly Known As
Lumira Capital
Investor Status
Actively Seeking New Investments
Trade Association
Canadian Venture Capital and Private Equity (CVCPE)
Year Founded
1989
Primary Investor Type
Venture Capital
Primary Office
  • 141 Adelaide Street
  • Suite 770
  • Toronto, Ontario M5H 3L5
  • Canada

+1 (416) 000-0000

Lumira Ventures Investments (123)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Notch Therapeutics 05-Nov-2019 Early Stage VC Drug Discovery Generating Revenue
0000000000 03-Oct-2019 0000 00000 00.000 Biotechnology Startup
0000000000 01-Oct-2019 00000 00000 0000 Monitoring Equipment Generating Revenue 00000 00000
0000000 0000000000 24-Apr-2019 00000 00000 0000 Pharmaceuticals Generating Revenue/Not Profitable 00000 00000
00000 00000000000 16-Apr-2019 00000 00000 000.00 Monitoring Equipment Generating Revenue 00000 00000
00000000000 08-Apr-2019 00000 00000 0000 Surgical Devices Pre-Clinical Trials 00000 00000
00000000 05-Feb-2019 00000 00000 00.00 Surgical Devices Generating Revenue 00000 00000
000000 18-Jan-2019 00000 00000 Biotechnology Generating Revenue 00000 00000
Antios Therapeutics 27-Nov-2018 Early Stage VC 0000 Drug Discovery Startup 00000000 00000000 00.0
Antiva Biosciences 10-Jul-2018 Later Stage VC 0000 Biotechnology Clinical Trials - Phase 1 00000000 00000000 00.0
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Lumira Ventures’s full profile, request a free trial.

Lumira Ventures Exits (58)

Company Name Exit Date Exit Type Exit Size Status Buyers
Satsuma Pharmaceuticals 13-Sep-2019 IPO 000.00 Completed
000000 0000000 19-Jun-2019 0000000000: 000000 Completed
000000 00000000 30-Apr-2018 000000000000000000 00000 Completed
  • 00000000 000000000
00 000000000000 31-Mar-2018 000000000 00000000 Completed
0000000 0000000000 01-Sep-2017 000 00 00000000 Completed
00000000 000000000 01-Jul-2017 000 00 00000000 Completed
00 000000000000 17-May-2017 000 00000 Completed
  • 00000000 0000000 0
000000000 28-Apr-2017 000 0000 Completed
Aurinia Pharmaceuticals 17-Mar-2017 Public Investment 2nd Offering 00000 Completed
Argos Therapeutics 23-Mar-2016 Secondary Transaction - Open Market Completed
To view this investor’s complete exits history, request access »

Lumira Ventures Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is reserved for PitchBook Platform accredited users. To explore Lumira Ventures‘s full profile, request access.

Request full access to PitchBook

Lumira Ventures Team (31)

Name Title Deals Funds Boards Office Contact
Info
Benjamin Rovinski Ph.D Managing Director 0 0 0 Toronto, Canada
Daniel Hetu MD Managing Director 0 0 0 Montreal, Canada
Gerry Brunk Managing Director 00 0 0 Waltham, MA
Peter Van der Velden Managing General Partner 0 0 0 Toronto, Canada
Brent Norton MD Venture Partner 0 0 Toronto, Canada

15 Former Team Members

You’re viewing 5 of 31 team members. Get the full list »